National Health Investors (NHI) Stock Price, News & Analysis

Company Overview

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Key Stats

• Today's Range: $72.17 to $74.53
• 50-Day Range: $65.77 to $76.02
• 52-Week Range: $57.95 to $86.13
• Volume: 165,290 shs
• Average Volume: 218,902 shs
• Market Capitalization: $3.46 billion
• P/E Ratio: 25.47
• Dividend Yield: 4.86%
• Price Target: $85.50
• Consensus Rating: Moderate Buy

National Health Investors Stock Analysis - MarketRank™

National Health Investors scored higher than 75% of companies evaluated by MarketBeat, and ranked 513th out of 951 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

National Health Investors has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

National Health Investors has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: 5.67%

Earnings Growth

Earnings for National Health Investors are expected to grow by 5.67% in the coming year, from $4.41 to $4.66 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of National Health Investors is 25.58, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.09.

Price to Earnings Ratio vs. Sector

The P/E ratio of National Health Investors is 25.58, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 21.54.

Price to Earnings Growth Ratio

National Health Investors has a PEG Ratio of 4.42. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

National Health Investors has a P/B Ratio of 2.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.69% of the float of National Health Investors has been sold short.

Short Interest Ratio / Days to Cover

National Health Investors has a short interest ratio ("days to cover") of 7.3.

Change versus previous month

Short interest in National Health Investors has recently decreased by 22.27%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

National Health Investors is a leading dividend payer. It pays a dividend yield of 5.02%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

National Health Investors does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of National Health Investors is 115.38%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on EPS estimates, National Health Investors will have a dividend payout ratio of 77.25% in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend.

Sustainability and ESG

• Score: 4.1 / 5
• Environmental Score: -2.59

Percentage of Shares Shorted

3.69% of the float of National Health Investors has been sold short.

Short Interest Ratio / Days to Cover

National Health Investors has a short interest ratio ("days to cover") of 7.3.

Change versus previous month

Short interest in National Health Investors has recently decreased by 22.27%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.60

News Sentiment

National Health Investors has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for National Health Investors this week, compared to 4 articles on an average week.

Search Interest

Only 1 people have searched for NHI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

3 people have added National Health Investors to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, National Health Investors insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 7.26% of the stock of National Health Investors is held by insiders.

Percentage Held by Institutions

62.51% of the stock of National Health Investors is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

NHI Stock Analysis - Frequently Asked Questions

How have NHI shares performed this year?

National Health Investors' stock was trading at $69.30 on January 1st, 2025. Since then, NHI shares have increased by 7.4% and is now trading at $74.43.
View the best growth stocks for 2025 here.

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) issued its quarterly earnings data on Tuesday, February, 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, beating analysts' consensus estimates of $1.10 by $0.03. The real estate investment trust had revenue of $85.75 million for the quarter, compared to the consensus estimate of $81.13 million. National Health Investors had a trailing twelve-month return on equity of 10.11% and a net margin of 38.53%.
Read the conference call transcript.

Who are National Health Investors' major shareholders?

Top institutional investors of National Health Investors include Rhumbline Advisers (0.17%), NBC Securities Inc. (0.04%) and GAMMA Investing LLC (0.03%). Insiders that own company stock include Robert G Adams, Charlotte A Swafford and James R Jobe.
View institutional ownership trends.

How do I buy shares of National Health Investors?

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some other companies that National Health Investors investors own include NVIDIA (NVDA), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Intel (INTC), Tesla (TSLA), Advanced Micro Devices (AMD) and Exxon Mobil (XOM).

Company Calendar

• Record date for 1/29 Dividend: 12/31/2024
• Ex-Dividend for 1/29 Dividend: 12/31/2024
• Dividend Payable: 1/29/2025
• Last Earnings: 2/25/2025
• Record date for 5/2 Dividend: 3/31/2025
• Ex-Dividend for 5/2 Dividend: 3/31/2025
• Today: 4/14/2025
• Dividend Payable: 5/02/2025
• Next Earnings (Estimated): 5/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: Real estate investment trusts
• Sub-Industry: Specialized REITs
• Current Symbol: NYSE:NHI
• CIK: 877860
• Web: www.nhireit.com
• Phone: (615) 890-9100
• Fax: 615-225-3030
• Employees: 20
• Year Founded: 1991

Price Target and Rating

• Average Stock Price Target: $85.50
• High Stock Price Target: $92.00
• Low Stock Price Target: $76.00
• Potential Upside/Downside: +15.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $3.12
• Trailing P/E Ratio: 25.47
• Forward P/E Ratio: 16.81
• P/E Growth: 4.42
• Net Income: $135.65 million
• Net Margins: 38.53%
• Pretax Margin: 38.18%
• Return on Equity: 10.11%
• Return on Assets: 5.12%

Debt

• Debt-to-Equity Ratio: 0.92
• Current Ratio: 10.29
• Quick Ratio: 10.29

Sales & Book Value

• Annual Sales: $335.18 million
• Price / Sales: 10.33
• Cash Flow: $5.20 per share
• Price / Cash Flow: 14.26
• Book Value: $29.13 per share
• Price / Book: 2.54

Miscellaneous

• Outstanding Shares: 46,693,000
• Free Float: 42,124,000
• Market Cap: $3.46 billion
• Optionable: Optionable
• Beta: 0.79